Island's health body will keep public informed
A pilot project to provide cradle to grave genome sequencing of 100,000 new-born babies in England is being monitored by Manx Care.
It could identify around 200 treatable, rare genetic diseases at an early stage.
The £105 million scheme by Genomics England, on behalf of the UK Department of Health and Social Care, could pave the way for routine testing of all babies
Manx Care has told Manx Radio NHS England monitors the delivery of the genomic service in the UK and the Genomic Medicine Service Alliance is responsible for extending testing throughout its network.
The health body will be determining its plans of extending the service to Crown Dependencies, including the Isle of Man, and has given an assurance that the public will be kept informed.
Researchers will be focussing their attention on diseases that are treatable and affect children up to the age of five.
Teresa Cope 'an extraordinarily dedicated public servant' who wasn't pushed out of job, says Manx Care chair
Ramsey Minor Injuries Unit to reopen next week
Local pharmacist believes gap to GP's is "narrowing"
Young farmer hopes to shine light on mental health
Manx Care: Hospital pressures beginning to ease after OPEL 4 escalation